Unveiling Biogen (BIIB) Q1 Outlook: Wall Street Estimates for Key Metrics

Wall Street analysts forecast that Biogen Inc. (BIIB) will report quarterly earnings of $3.32 per share in its upcoming release, pointing to a year-over-year decline of 9.5%. It is anticipated that revenues will amount to$ 2.23 billion, exhibiting a decline of 2.6% compared to the year-ago quarter.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted upward by 0.1% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projection ...